To further investigate the connection involving TDP43 expression and clinical BC, we employed tissue microarray technology to observe the expression of TDP43 in BC patients with different pathological features (Figure S3A–C), and according to the results, 51% of BC tissues were positive for TDP43 expression (29/57). This evidence concerns the gene TARDBP and breast cancer.